What is rapidly progressive glomerulonephritis, and how should it be managed?

Jul 29, 2023 Source: Cainiu Health
Dr. Zhao Xinju
Introduction
Rapidly progressive glomerulonephritis is a severe kidney disease characterized by rapidly advancing glomerular inflammation, typically leading to a sharp deterioration in renal function within weeks to months. Common causes of rapidly progressive glomerulonephritis include drug-induced conditions, anti-glomerular basement membrane antibody-mediated glomerulonephritis, parasitic infections, crescentic glomerulonephritis, and immune complex-mediated glomerulonephritis.

Rapidly progressive glomerulonephritis (RPGN) is a severe kidney disease characterized by rapidly advancing glomerular inflammation, typically leading to a sharp deterioration in renal function within weeks to months. In general, the causes of RPGN include drug-induced factors, anti-glomerular basement membrane (anti-GBM) antibody-mediated glomerulonephritis, parasitic infections, common types of nephritis, and immune complex-mediated glomerulonephritis. Treatment should be tailored according to the specific underlying cause. Detailed analysis is as follows:

1. Drug-induced: Certain medications may trigger the development of RPGN, particularly antibiotics, nonsteroidal anti-inflammatory drugs (NSAIDs), and other agents. Symptoms usually improve only after discontinuation of the offending drug.

2. Anti-glomerular basement membrane (anti-GBM) antibody-mediated glomerulonephritis: This is a common cause of RPGN. The immune system produces antibodies that attack the glomerular basement membrane, resulting in inflammation and tissue damage. Patients may be treated under medical supervision with medications such as ifosfamide for injection, methotrexate tablets, and methylprednisolone sodium succinate for injection.

3. Parasitic infection: Certain parasitic infections, such as schistosomiasis, can lead to deposition of parasite eggs in the glomeruli, triggering an inflammatory response that may ultimately result in RPGN. Under medical guidance, patients may be treated with medications such as albendazole tablets, praziquantel tablets, or acetylspiramycin tablets.

4. Common types of nephritis: Some forms of nephritis, such as focal segmental glomerulosclerosis and IgA nephropathy, may progress to RPGN, especially if not promptly treated. Patients may follow medical advice to use medications such as furosemide tablets, valsartan hydrochlorothiazide tablets, or penicillin V potassium tablets to improve their condition.

5. Immune complex-mediated glomerulonephritis: Immune complexes—structures composed of antibodies bound to antigens—can deposit in the glomeruli, initiating an inflammatory response. This process may lead to RPGN. In severe cases, treatment under medical supervision may include prednisone acetate tablets, compound captopril tablets, or dipyridamole tablets.

If any of the above conditions occur, prompt medical attention is recommended. Evaluation and treatment planning should be conducted by a multidisciplinary team led by specialists in nephrology or immunology.

Related Articles

View All